Mystaire® Misonix® is pleased to announce the release of the complete range of Aura® ESD ductless chemical fume hoods

Creedmoor, NC - Mystaire® Misonix® is pleased to announce the release of the complete range of Aura® ESD ductless chemical fume hoods designed for electrostatic-sensitive applications. Aura®’s superior user protection against toxic fume exposure has been combined with electrostatic dissipative features to prevent static build-up and discharge. The addition of electrostatic dissipation coupled with Aura®’s [...]

Glencoe Software Unveils New Website

Glencoe Software, the global leader in viewing, sharing and analyzing life science images and data from a single software framework, announced today the release of their new website at www.glencoesoftware.com. Glencoe Software updated the design and content of the site to meet the growing demands in the research, clinical and biopharma communities to quickly and [...]

SISCAPA Assay Technologies Announces a Publication on LC-free SISCAPA-MALDI-TOF Assay for Protein C Inhibitor and its Application to Monitoring Recurrence of Prostate Cancer

Washington, DC -- SISCAPA Assay Technologies, Inc. (SAT) announced publication of a study in Clinical Chemistry demonstrating that a SISCAPA-MALDI-TOF assay for protein C inhibitor can help identify patients at risk for recurrence of prostate cancer after radiotherapy. The assay measures a proteotypic peptide of protein C inhibitor enriched from tryptic digests of patient serum [...]

Meridian Life Science® Successfully Manufactures Influenza Challenge Stock for Immune Targeting Systems

CINCINNATI -- Meridian Life Science, Inc., (MLS) of Memphis, Tennessee, a wholly-owned subsidiary of Meridian Bioscience, Inc. (NASDAQ:VIVO), is proud to announce that MLS manufactured an H1N1 influenza A challenge stock for Immune Targeting Systems, Ltd. Immune Targeting Systems contracted Meridian Life Science to manufacture the influenza A challenge stock resulting in a 12-month, highly [...]

New Consolidated Cardiac and STAT Quality Control

FREMONT, Calif.--Clinical laboratory staff now have a tool that combines routine and cardiac/STAT monitoring markers for patients without the need for separate QC. The Thermo Scientific MAS Omni•CARDIO controls consolidate routine cardiac markers including Troponin I and T, CK-MB, Myoglobin, NT-proBNP and BNP-32 with several new cardiac/STAT markers including Myeloperoxidase, hCG, D-Dimer and Procalcitonin. These [...]

New Liquid, Ready-to-Use Tacrolimus Immunoassay to Help Simplify Therapeutic Drug Monitoring

FREMONT, Calif.--Transplant physicians working with clinical laboratories must carefully monitor and manage dosages of immunosuppressant drugs—too low, and the patient may reject a transplanted organ; too high, and toxicity problems arise. To improve monitoring of one of the most commonly prescribed immunosuppressant drugs, tacrolimus, Thermo Fisher Scientific has unveiled the Thermo Scientific QMS Tacroliums Immunoassay, [...]

Accelerated Technology Laboratories, Inc. (ATL) and Institute for Biopharmaceutical Research (IBR, Inc.) Partner to Provide Pipette Calibration Solutions for GLP and GMP Compliant Laboratories

Lauchefeld, Switzerland & West End, NC : Accelerated Technology Laboratories, Inc. (ATL), a leading supplier of Laboratory Information Management Systems (LIMS), is excited to announce a new partnership with Institute for Biopharmaceutical Research (IBR, Inc.) -a leader in turnkey calibration software. ATL is the North American Partner for IBR and will be offering Check&Track v2.0 [...]

Roche unveils intelligent automation management solution at 2013 Clinical Lab Expo

HOUSTON -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced plans today at the AACC 2013 Clinical Lab Expo for the U.S. introduction of the cobas 8100 automated workflow series, an advanced system designed to automate many routine tasks to help diagnostic laboratories increase efficiency, reduce expenses and maximize patient safety. "This total lab automation solution [...]

AD HOC Announcement According to §15 WpHG: QIAGEN to conduct new $100 million share repurchase program

Venlo, The Netherlands, - QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) announced today that its Managing Board, upon authorization of the Supervisory Board, has passed a resolution to exercise the authorization granted by the General Meeting of Shareholders on June 26, 2013, and to purchase shares in the Company up to a total of [...]

Morpho Detection Appoints Karen Bomba President and CEO

Newark, Calif. - Morpho (Safran), through its subsidiary Morpho Detection, Inc., today announced the appointment of Karen Bomba to President and CEO, effective immediately. Bomba brings more than a decade of executive experience leading Safran companies to the role. Most recently, Bomba served as Chairman and CEO of Labinal, Safran's electrical wiring systems company. Bomba [...]

Access IBO on Knowledge Center